Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

Overview of attention for article published in Cardiovascular Diabetology, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#46 of 1,770)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 5 news outlets
policy: 1 policy source

twitter: 29 X users

Citations

dimensions_citation: 117 Dimensions

Readers on

mendeley: 119 Mendeley

Summary News Policy documents X Dimensions citations

So far, Dimensions has found 117 publications that cite this research output.

117

The most recent citing publications are shown below. View all 117 publications that cite this research output on Dimensions.

Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.

Article in NEJM Evidence (September 2024)

Diabetes and Stroke—A Focused Review

Article in Journal of Diabetology (July 2024)

The potential anti-arrhythmic effect of SGLT2 inhibitors

Article in Cardiovascular Diabetology (July 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.